Status:
TERMINATED
Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
Lead Sponsor:
Ullevaal University Hospital
Conditions:
Heart Failure
Cardiac Surgery
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Hypothesis: Treatment with levosimendan will preserve myocardial function and hemodynamics after cardiac surgery and lead to reduced stay at intensive care unit
Detailed Description
Single center, prospective, randomized parallel-group, double-blinded study
Eligibility Criteria
Inclusion
- EF (ejection fraction)\<40%
Exclusion
- renal failure, liver failure
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT01221116
Start Date
January 1 2003
End Date
December 1 2008
Last Update
November 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Cardiothoracic Anesthesia, Ullevål University Hospital
Oslo, Oslo County, Norway, 0407